Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland F Staack

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Cancer Chemotherapy and Pharmacology|March 19, 2017
An apparent clinical pharmacokinetic drug-drug interaction between bevacizumab and the anti-placental growth factor monoclonal antibody RO5323441 via a target-trapping mechanismKa Wang, Franziska Schaedeli Stark, Tilman Schlothauer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 22, 2019
Are Biotransformation Studies of Therapeutic Proteins Needed? Scientific Considerations and Technical ChallengesSimone Schadt, Simon Hauri, Filipe Lopes, et al.
The AAPS Journal|April 30, 2015
Workshop Report: AAPS Workshop on Method Development, Validation, and Troubleshooting of Ligand-Binding Assays in the Regulated EnvironmentMarian Kelley, Lauren Stevenson, Michaela Golob, et al.
Bioanalysis|February 18, 2026
Implementation of the fully automated diagnostic immunoanalyzer cobas e411 in the bioanalytical laboratory - Lessons learntThomas Emrich, Eginhard Schick, Andreas Wolfert, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 20, 2016
Immunogenicity, Inflammation, and Lipid Accumulation in Cynomolgus Monkeys Infused with a Lipidated Tetranectin-ApoA-I Fusion ProteinFranziska Regenass-Lechner, Roland F Staack, Jean-Luc Mary, et al.
Bioanalysis|October 4, 2021
Recommendations and discussion points on immunogenicity, biomarkers, automation/technology and protein-MS from the 2021 European Bioanalysis Forum Focus WorkshopsPhilip Timmerman, Matthew Barfield, Kyra Cowan, et al.
Bioanalysis|January 27, 2023
Conference Report from the European Bioanalysis Forum Workshop: toward harmonized implementation of the ICH M10 guidelinePhilip Timmerman, Matthew Barfield, Kyra Cowan, et al.
Analytical Chemistry|February 5, 2019
High-Throughput, Sensitive LC-MS Quantification of Biotherapeutics and Biomarkers Using Antibody-Free, Peptide-Level, Multiple-Mechanism Enrichment via Strategic Regulation of pH and Ionic and Solvent StrengthsBo An, Ming Zhang, Jie Pu, et al.
Archives of Biochemistry and Biophysics|April 3, 2012
Development of tetravalent IgG1 dual targeting IGF-1R-EGFR antibodies with potent tumor inhibitionRebecca Croasdale, Katharina Wartha, Juergen M Schanzer, et al.
Frontiers in Oncology|April 5, 2024
Phase 1, first-in-human study of TYRP1-TCB (RO7293583), a novel TYRP1-targeting CD3 T-cell engager, in metastatic melanoma: active drug monitoring to assess the impact of immune response on drug exposureAnna Spreafico, Eva Muñoz Couselo, Anja Irmisch, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Cancer Chemotherapy and Pharmacology|March 19, 2017
An apparent clinical pharmacokinetic drug-drug interaction between bevacizumab and the anti-placental growth factor monoclonal antibody RO5323441 via a target-trapping mechanismKa Wang, Franziska Schaedeli Stark, Tilman Schlothauer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 22, 2019
Are Biotransformation Studies of Therapeutic Proteins Needed? Scientific Considerations and Technical ChallengesSimone Schadt, Simon Hauri, Filipe Lopes, et al.
The AAPS Journal|April 30, 2015
Workshop Report: AAPS Workshop on Method Development, Validation, and Troubleshooting of Ligand-Binding Assays in the Regulated EnvironmentMarian Kelley, Lauren Stevenson, Michaela Golob, et al.
Bioanalysis|February 18, 2026
Implementation of the fully automated diagnostic immunoanalyzer cobas e411 in the bioanalytical laboratory - Lessons learntThomas Emrich, Eginhard Schick, Andreas Wolfert, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 20, 2016
Immunogenicity, Inflammation, and Lipid Accumulation in Cynomolgus Monkeys Infused with a Lipidated Tetranectin-ApoA-I Fusion ProteinFranziska Regenass-Lechner, Roland F Staack, Jean-Luc Mary, et al.
Bioanalysis|October 4, 2021
Recommendations and discussion points on immunogenicity, biomarkers, automation/technology and protein-MS from the 2021 European Bioanalysis Forum Focus WorkshopsPhilip Timmerman, Matthew Barfield, Kyra Cowan, et al.
Bioanalysis|January 27, 2023
Conference Report from the European Bioanalysis Forum Workshop: toward harmonized implementation of the ICH M10 guidelinePhilip Timmerman, Matthew Barfield, Kyra Cowan, et al.
Analytical Chemistry|February 5, 2019
High-Throughput, Sensitive LC-MS Quantification of Biotherapeutics and Biomarkers Using Antibody-Free, Peptide-Level, Multiple-Mechanism Enrichment via Strategic Regulation of pH and Ionic and Solvent StrengthsBo An, Ming Zhang, Jie Pu, et al.
Archives of Biochemistry and Biophysics|April 3, 2012
Development of tetravalent IgG1 dual targeting IGF-1R-EGFR antibodies with potent tumor inhibitionRebecca Croasdale, Katharina Wartha, Juergen M Schanzer, et al.
Frontiers in Oncology|April 5, 2024
Phase 1, first-in-human study of TYRP1-TCB (RO7293583), a novel TYRP1-targeting CD3 T-cell engager, in metastatic melanoma: active drug monitoring to assess the impact of immune response on drug exposureAnna Spreafico, Eva Muñoz Couselo, Anja Irmisch, et al.
Pageof 9